Watch: RFK Jr., Mary Holland Join CHD Europe for Webinar on HPV Vaccines

Robert F. Kennedy Jr., Children’s Health Defense (CHD) founder and chairman on leave, and CHD President Mary Holland joined CHD Europe and parents of injured children to discuss the risks and false promises of the human papillomavirus vaccine.

This article was originally published by The Defender — Children’s Health Defense’s News & Views Website.

Children’s Health Defense (CHD) Europe on Sept. 22 held a live event on the human papillomavirus (HPV) vaccines and their effect on real people.

The event included stories from parents whose children experienced adverse events, data on the vaccines’ harms and flawed clinical trials, and strategies for overcoming pressure for children to receive them.

Robert F. Kennedy Jr., CHD chairman on leave, spoke via video. CHD President Mary Holland, CHD Acting General Counsel Kim Mack Rosenberg, several medical experts and researchers, and parents of children injured by the HPV vaccine also participated.

HPV vaccine a ‘precursor for the COVID vaccines’

Holland, who along with Rosenberg co-authored “The HPV Vaccine on Trial: Seeking Justice for a Generation Betrayed,” told viewers, “In many ways, the rollout of the HPV vaccine, starting in the early 2000s, was the precursor for the COVID vaccines. And it has many of the same issues in common that we see with COVID.”

Holland said 90% of cervical infections “clear completely on their own,” adding:

“The woman or girl has no knowledge that she has it. They clear within two years … It’s only 0.6% of American women who are truly at risk of getting cervical cancer in their lifetimes. And the typical age of onset of cervical cancer is a woman in her 50s.

“If you have regular pap screening, if you have screening of the cervix for women, there’s no rationale for these shots or a very, very limited one. If you go for screening, if there’s some kind of precancerous or abnormal growth, it will be detected.”

But that’s not what Merck, manufacturer of the Gardasil vaccine, told the U.S. Food and Drug Administration (FDA), Holland said. “They presented that the risks were much higher.”

When Merck first developed the Gardasil vaccine, it had just suffered a very serious economic catastrophe involving its then-blockbuster drug, Vioxx, which the drugmaker voluntarily pulled from the market “because there were so many injuries” and potential “fraud in the marketing” of the drug, Holland said.

“Word on the street … was that HPV vaccines helped pay for Vioxx,” Holland said.

Holland described Merck’s push to get quick FDA approval for Gardasil, and the company’s aggressive 2008 marketing campaign to get the drug quickly marketed and sold around the world.

“The media picked up on that in a big way,” she said. “The media makes most of its revenue [in the U.S.] from advertising from the pharmaceutical industry.”

Holland described how Merck first introduced Gardasil with the idea of protecting women in the developing world from the scourge of cervical cancer,” but was soon selling it aggressively in Western Europe, the U.S. and other developed countries.

“This is literally a golden goose,” Holland said.

“You have to remember that for vaccines — uniquely [among] almost all other consumer products — they have the benefit of so-called ‘no liability’ in the United States,” Holland said. Those laws have been “modeled around the world and copied.”

Pharmaceutical companies are making in the range now of $5 billion to $6 billion from HPV vaccines, Holland said, noting that “their target is $10 billion per year by 2030.”

She pointed out that because U.S. government scientists participated in the discovery of the technology in the HPV vaccines, “the government itself makes revenue on these shots.” “There’s an overt conflict of interest that the National Institutes of Health make royalties on this.”

Effectiveness of HPV vaccines ‘absolutely a fiction’

But do the vaccines work?

“HPV vaccines have never been proven to prevent a single case of cancer,” Holland said. “The clinical trials did not prove that these shots prevent cancer, although that’s how they’re promoted and how they’re sold.”

Holland described Merck’s use of “surrogate endpoints” — alleged precursors for cancer — to predict how well the shots would work against cancer. “That in and of itself is absolutely a fiction,” she said.

Dr. Gerald Delépine, a French orthopedic surgeon and oncologist, presented data from several countries demonstrating that cervical cancer rates, which were on the decline prior to the introduction of HPV vaccines, have stopped declining or, in certain instances, have begun increasing again.

“Australia was the first country who recommended the HPV vaccine at school, and they’d start very early,” Delépine said. In the period before 2006, before HPV vaccines were administered, cervical cancer incidences had declined by “almost 50%.

However, in the post-2006 period, with regular vaccination, “no more reduction was observed,” he said. “So, when they say a vaccine can reduce the incidence of cervical cancer, that is completely false.”

According to Holland, trouble was evident early in the development of the HPV vaccines, noting that “the clinical trials were fatally flawed.”

“We believe that there was explicit, overt fraud in the clinical trials, and we believe there’s been much coverup of that fraud on an ongoing basis,” she said.

Rosenberg said that during these trials, very few people in the control group “got anything even resembling” an inert placebo. Instead, she said the vast majority of the thousands of young women (and some boys) participating in the clinical trials received the same aluminum compound used in the vaccines.”

“When they saw similar rates, for example, of autoimmune conditions between the vaccinated population and those who got a control … They used that to say that the vaccine was safe because … it was identical when compared to the control,” she said.

Holland said:

“Over 50% of the girls … developed what were euphemistically called by Merck ‘medical conditions.’ There were very clear signals from the get-go that these vaccines were going to cause severe problems.

“It was also clear … that these shots were causing reproductive harm. They were causing miscarriages and other reproductive problems, including infertility.”

Yet, many of these conditions were not recorded because clinical trial administrators were looking for adverse events only within the first 14 days, according to Rosenberg.

“Autoimmune conditions … can take years to develop, years to diagnose” and are often composed of a “constellation of symptoms” that is typically “difficult to diagnose,” she said.

Yet, according to Delépine, many doctors are reluctant to openly draw a connection between a patient’s condition and the HPV vaccine. “Doctors are afraid to send this observation to the authorities because then they are said to be ‘anti-vaxxers,’” he said.

Kennedy said the U.S. Vaccine Adverse Event Reporting System (VAERS) “simply does not work,” as research has found that “fewer than 1% of adverse events from vaccines are ever recorded.”

According to Kennedy, “India suspended its Gardasil trials after numerous deaths and serious injuries” and “Japan de-recommended it three months after adding it to the immunization schedule.”

Kennedy said that Japanese authorities discovered adverse events reported after Gardasil’s approval were many times higher than other vaccines [and] included seizures, severe headaches, partial paralysis, complex regional pain syndrome and a miscarriage rate of up to 30%.

“Although the prevention of cancer is … fanciful, the injuries that have been caused are real,” Holland said, adding that the U.S. Vaccine Injury Compensation Program (VICP) has issued decisions “proving that Gardasil caused death in at least a few cases.”

Parents of HPV vaccine victims describe gaslighting, censorship

Parents who spoke during the webinar shared harrowing details about their children’s reactions to HPV vaccines

Mandeep Badial, a former Johnson & Johnson employee, described how her daughter was injured by the Gardasil vaccine.

“My daughter was very young. She was in a girls’ school. She was not sexually active … she really shouldn’t have even had the jab,” Badial said. “But it was very much forced by the district nurses who came to the school and said, ‘You need to get this done. You’ll get cancer unless you have this injection.’”

Other parents described similar pressures and gaslighting.

Amanda Dew, whose daughter was injured by Gardasil, said she refused the HPV vaccine for her daughter at age 12.

“I said, ‘No, I didn’t think it was a good idea. A 12-year-old, it wasn’t necessary for her.’ She said to me, ‘Oh, right, so you don’t care about cervical cancer then,’” Dew said.

After her daughter’s second dose, “everything changed,” Dew said. “She had a seizure, and I thought, this can’t be right. She’s never even fainted in her life. She was so healthy.” Despite this, doctors said, “it was just a one-off” and that she was likely “a bit stressed.”

Dew said:

“She’s had, probably, nearly a hundred seizures in the last eight years.

“She’s got so many other symptoms as well. Balance issues, blurred vision. She sweats incredibly, fatigue, headaches, menstrual issues, but perhaps for her, the worst thing about it has been her [decline in] cognitive function and her imagination.”

Caron Ryalls’ daughter was injured by the Cervarix HPV vaccine, after getting a series of doses of the vaccine at ages 12 and 13.

She said that before her daughter’s vaccination, “She was a high achiever … and she was very sporty. She danced competitively and she played sports competitively. She was very healthy.”

“It was a big shock when she became ill after the first vaccine,” Ryalls said. “She was ill for two weeks after the jab [and] she was in bed for about three weeks.”

A few weeks later, after she returned to school, Ryalls’ daughter suffered a seizure.

“She didn’t move. She didn’t wake for the toilet. She didn’t have anything to eat or drink. She just slept.” Ryalls said this soon became a recurring cycle.

“And then, after the second vaccine, she got more ill. It was more frequent,” she said.

After the third dose, severe neurological issues followed. “She would lose feeling. She couldn’t stand to have light in her bedroom. Everything had to be dimmed. She had horrific headaches. She had to crawl to the bathroom on her hands and knees because she couldn’t stand up without passing out,” Ryalls said.

“It took us two years of solid research and visiting numerous doctors to work out she had POTS [postural orthostatic tachycardia syndrome], which has been linked to the HPV vaccine in various studies,” she added.

Steve Hinks also described being gaslighted by doctors. He said when he was informed by his daughter’s school that she was eligible for the HPV vaccine, “we chose not to consent,” as she “had quite a severe adverse reaction to the MMR vaccine as a baby.”

“The nurse at the school … explained to my wife that we were denying [my daughter] a vaccine that could save her life,” he said. “My wife reluctantly signed the consent form.”

After the second dose, his daughter “struggled and had to go to the doctor for aches and pains.” And after the third dose, “she had an immediate reaction. She was in pain, [had] violent headaches and couldn’t stay awake.”

Some parents said that when they tried to share their stories, they were censored.

“At one point I was asked to go and give an interview with [British national broadcaster] ITV,” Dew said. “When I got there, I wasn’t allowed in the building. The person I was meant to be interviewed by had disappeared.”

Similarly, Ryalls talked about working with a Sunday Times journalist for nearly 12 months and being assured there would publish a half-page article. “And at the 11th hour,” he said, “we received an email saying, ‘Unfortunately it won’t be going ahead.’ Same thing happened with [British broadcaster] Sky News.”

When the Sunday edition of The Independent published her daughter’s story, Ryalls said her daughter “received death threats on social media, saying … she’d lied” and messages wishing that she “get cervical cancer and die.”

Badial, who lives in the U.K., said that the member of parliament for her district is former British Prime Minister Theresa May, with whom she met to discuss her daughter’s condition. However, May told her, “We have a big pharmaceutical industry” in the district, implying that “politically they can’t rock the boat,” Badial said.

“That’s what we’re up against,” Ryalls said. “The censorship is horrific and we’re up against a concerted effort not to get the information out there.”

Hinks, who helped found SaneVax (Safe, Affordable, Necessary Vaccines) and the Facebook group, “Parents of sons and daughters suffering illness after HPV vaccine,” said he developed a questionnaire and that of the 94 responses, most girls said they sustained adverse reactions within a month of vaccination.

Yet, British medical authorities “ignored us, and they just carried on,” he said.

“There’s a total lack of compassion, and it shocked me to the core that the doctors, nurses, schools, people could be so completely callous,” Dew said.

Some outreach successes were highlighted, however.

Elin, teacher and activist in France, who works with CHD Europe, said that a vaccine injury court case involving Gardasil garnered significant publicity in France in 2013, raising awareness among parents in the country.

“I think it put a lot of French people off the HPV vaccine because we have quite low numbers [of vaccination] in France,” she said.

Elin reported on a nation-wide campaign in France encouraging school administrators and parent-teacher associations to opt out of the establishment of school-based vaccination clinics as well as asking them to inform parents about the very real risks associated with this vaccine.

This “amazing effort” targeting lower-level school administrators instead of politicians or the government, has been a successful strategy, Elin said.

Elin told The Defender that “In France, several catholic secondary schools have already withdrawn from the HPV vaccination campaign,” noting that school officials have expressed concerns about safety and a lack of resources.

“In-school vaccination is inherently risky,” she added. “In most cases there is no doctor present to go through the child’s medical history, allergies and existing medical conditions in order to perform an individual risk/benefit assessment. And if the child has an immediate allergic response to the vaccine, a school environment is not necessarily equipped to handle these adverse events.”

Dew advised parents that if “your child does have a reaction, never give up trying to get them better,” sharing that her daughter completed her degree and became a biochemist.

Holland commented on the progress she’s seen:

“The good news is that we’re having this gathering and that the uptake has been low. We have foiled Big Pharma’s plans … there is a lot of skepticism worldwide about this shot, and I hope that initiatives like this forum and others will continue to keep that skepticism alive.”

Watch the webinar here or on the CHD Europe website here (ed.)

The Defender on occasion posts content related to Children’s Health Defense’s nonprofit mission that features Mr. Kennedy’s views on the issues CHD and The Defender regularly cover. In keeping with Federal Election Commission rules, this content does not represent an endorsement of Mr. Kennedy who is on leave from CHD and is seeking the Democratic nomination for president of the U.S.

This article was originally published by The Defender

Suggest a correction